The human genome project paved the way to elucidation of a wide spectrum of cardiovascular diseases. In particular, the genetic basis of frequent disorders such as coronary artery disease or atrial fibrillation, quantitative traits such as blood pressure or cholesterol levels, as well as a wide spectrum of rare monogenic conditions such as cardiomyopathies or rhythm disorders were unravelled in recent years. [1] [2] [3] [4] [5] [6] Progress in the field of congenital heart disease (CHD) has been somewhat slower, despite a number of remarkable success stories. 7, 8 This can be explained neither by the lack of genetic causes nor by the low frequency of the condition. For example, a biscupid aortic valve disease is found in 1-2% of the overall population. Likewise, other congenital heart defects are found in 1% of all live born children. Moreover, accurate phenotyping nowadays allows a precise anatomical diagnosis in virtually all cases. Finally, the interest in genetic counselling of couples with a wish to have a baby clearly asks for precise information on inheritance patterns or risk of recurrence. Given these prerequisites and the medical needs, what makes it so difficult to pinpoint the causes of disease in children or adults with congenital heart defects?
One reason may be that developmental diseases such as CHD are tough nuts to crack with respect to their mode of inheritance. They may often fall in between, on the one hand, classical monogenic disorders that co-segregate in families with well-defined Mendelian patterns, and, on the other hand, complex diseases that are largely based on multiple common genetic variants with additive effects. 9 In other words, one explanation may be that the precipitation of CHD is driven by functionally additive mutations in a number of genes, i.e. the condition has an oligogenic mode of inheritance, which is challenging to identify by classical co-segregation analysis. 10 Furthermore, such a mode of inheritance may be complicated by exogenous factors during pregnancy which may also contribute to the rather phenotypically diverse appearance of CHD. Indeed, even in subjects with an identical genotype, i.e. monozygotic twins, different anatomical forms of CHD may occur with tremendous consequences with regard to therapeutic options, quality of life, and life expectancy ( Figure 1) .
In the present issue of the journal, Ellesøe and co-workers present the most comprehensive study on familial co-occurrence of CHD that has ever been conducted. 11 The authors need to be congratulated for a rather comprehensive and inclusive study on >3000 individuals with a clinically confirmed diagnosis of any form of congenital heart defect. In total, the study involved >10 000 subjects from families with at least two cases of one of 41 specific types of cardiac malformations. As a result of this laborious exercise, the authors can provide valuable preliminary information about concordantly or discordantly occurring heart defects within families. Such an analysis and the comprehensive material presented in the supplementary files of the study 11 will influence future genetic research on CHD. Now, given the new data, what is the recurrence risk of a heart malformation? This is still the most urgent and frequently asked question in the clinical context. Parents having a child affected by complex CHD or CHD patients who want to become parents themselves need precise answers. Yet, genetic counselling remains difficult and it might be disappointing to read that Ellesøe and co-workers-despite their considerable efforts-clearly state 'it is still not possible, . . . , to calculate recurrence risk from our data set'. 11 One reason is that the authors restricted their analysis to families with at least two affected members (giving rise to a sampling bias) and half of the families were derived from the literature (giving rise to a publication bias). Recurrence risks, however, are what future parents in families with CHD want to know the most. Ellesøe and co-workers used 41 diagnoses of the IPCCC system, one of the currently most sophisticated classifications of CHD. They grouped families with respect to the co-occurrence of anatomically concordantly or discordantly appearing forms of CHD. Like others, they found a higher degree of anatomically discordant rather than concordant defects within a given family. 12, 13 Of course, this might partially be caused by the high differentiation of phenotypes by the IPCCC system. Moreover, the authors may be criticized for including The authors went on to use hierarchical clustering and calculated odds ratios from the 1640 pairs of diagnoses. In contrast to others, they did not group patients according to morphological similarities, but by an 'unbiased, data-driven approach'. One result, which might be perceived as trivial, was that some groups consisted of already well-known co-occurrences such as tetralogy of Fallot together with ventricular septal defect. The fact, however, that these results were generated by a mathematical approach and yet led to similar results when compared with an established taxonomy based on anatomical and clinical classification 14 confirms the value of the method. On the other hand, the analysis led to a higher level of differentiation. For example, atrioventricular septal defects, which are morphologically seen as one phenotype, were grouped in two distinct groups: either a simple form related to mitral valve cleft and atrial septal defect of the primum type, or a complex form connected with heterotaxy. Thus, by mathematical grouping, it became possible to differentiate similar phenotypes to different developmental disorders. Several candidate genes have been found to be positively correlated with certain congenital heart defects. The penetrance of these genes, however, varies considerably and their overall role for the development of a certain defect remains weak or even unclear. Indeed, the data of Ellesøe and co-workers support the concept that a number of shared susceptibility genes still have a relatively undefined influence on the extent to which a heart defect is formed. However, if the grouping presented in the manuscript could be reproduced in even larger cohorts, it can be assumed that a more comprehensive understanding of the relationships between genetic deviations, environmental influences, and resulting phenotypes is possible. In analogy to Darwin's phylogenetic 'Tree of Life' and its variation over the last 150 years, we could start to draw a draft of an ontogenetic 'Tree of Congenital Heart Defects' (Figure 2) where phenotypes are classified according to developmental pathways influenced by groups of susceptibility genes and environmental factors until we obtain more complex insights into the understanding of individual disorders.
For the time being it can be concluded that the complexity of inheritance of CHDs is still considerable: monogenic aetiologies are more the exception than the rule, and in families with more than one affected member, inheritance of anatomically discordantly appearing forms is more frequent than that of concordant forms. In families with only one affected member it remains unclear whether the defect is a spontaneous mutation or driven by environmental factors (Figure 1) .
Finally, to find correlations between phenotype and genotype, it becomes clear that there are problems on both sides: The correlation is extremely influenced by the way in which phenotyping is performed, and there are different classification systems based on morphological criteria of congenital heart defects. Thus, in analogy to the history of phylogenetic sciences, the ontogenetic classification of congenital heart defects seems to be 150 years behind. Contributions like those from Ellesøe and co-workers, however, will hopefully offer the chance to catch up in a considerably shorter period of time.
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